当前位置： SCI文献检索 > LUPUS期刊下所有文献 > Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.

Clinical and immunological pattern and outcome of Egyptian systemic lupus erythematosus patients: a single center experience.

Abstract：

:Objective The objective of this study was to describe the clinical and immunological pattern and disease outcome in Egyptian systemic lupus erythematosus patients. Patients and methods The medical records of 770 systemic lupus erythematosus patients who were followed from 2002-2015 at Kasr Alainy Hospital, Cairo University, were retrospectively reviewed. Results There were 707 (91.8%) females. The mean age at disease onset was 22.1 ± 8.6 and the disease duration was 6.1 ± 4.5 years. The main clinical manifestations were mucocutaneous (90.8% with oral ulcers affecting 52.5%), arthritis (80.3%), nephritis (67.8%), hematologic involvement (64.9%), serositis (55.2%) and neuropsychiatric manifestations (44.3%). The frequencies of antinuclear antibodies were 94.3%, anti-dsDNA 74.8%, anti-Smith 11%, anticardiolipin antibodies 29.5% and lupus anticoagulant 19.8%. Infections, predominantly bacterial, affected 337 (43.8%) patients. Thirty-three (4.3%) patients died. The main causes of death were sepsis and disease activity. The five- and 10-year survival rates for the total cohort were 97.4% and 96.3%, respectively, and were 96% and 92%, respectively for those with nephritis ( p = 0.008). Autoimmune hemolytic anemia, thrombocytopenia, elevated serum creatinine, a higher damage index, infections, a higher glucocorticoid dose and cyclophosphamide use ≥ six months were associated with an increased risk of mortality with odds ratios of 3.69, p < 0.01; 4.12, p < 0.001; 1.54, p < 0.001; 1.43, p < 0.001; 5.08, p < 0.001; 5.04, p < 0.001 and 2.25, p = 0.03, respectively. Conclusion Compared to other cohorts, a relatively lower mean age at systemic lupus erythematosus onset and higher frequencies of oral ulcers, serositis and nephritis were found.

journal_name

Lupus

journal_title

Lupus

authors

Mahmoud GA,Shahin AA,Zayed HS,Moghazy A,Eissa BM

doi

10.1177/0961203318776085

subject

Has Abstract

pub_date

2018-08-01 00:00:00

pages

1562-1569

issue

9

eissn

0961-2033

issn

1477-0962

journal_volume

27

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Belimumab for systemic lupus erythematosus: a practice-based view.

    abstract：:Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder with multiple organ involvement. B-lymphocyte activity plays a pivotal role in the development and course of the disease. A newly developed agent called belimumab has recently been approved to treat active, autoantibody positive SLE as an add-on to st...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203313476154

    authors： Parodis I,Axelsson M,Gunnarsson I

    更新日期：2013-04-01 00:00:00

  • Antiphospholipid antibodies in alcoholic liver disease are influenced by histological damage but not by alcohol consumption.

    abstract：:Antiphospholipid antibodies (aPL) have been detected in various liver diseases, particularly cirrhosis. The role of alcoholic consumption per se has been suggested. The aim of our study was to assess the prevalence of aPL in patients with alcoholic liver disease at various states and to correlate the presence of aPL w...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1191/096120300678828659

    authors： Perney P,Biron-Andréani C,Joomaye Z,Fabbro-Peray P,Quénet F,Schved JF,Blanc F

    更新日期：2000-01-01 00:00:00

  • Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

    abstract：:We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/096120339700600108

    authors： Granados J,Vargas-Alarcón G,Drenkard C,Andrade F,Melín-Aldana H,Alcocer-Varela J,Alarcón-Segovia D

    更新日期：1997-01-01 00:00:00

  • Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.

    abstract：:High levels of serum and/or plasma circulating DNA (cDNA) have been described in patients with systemic autoimmune diseases (SADs). However, the role of this molecule has not been clarified. Our aim was to evaluate plasma cDNA levels in 48 systemic lupus erythematosus (SLE) and 44 primary Sjögren's syndrome (SS) patie...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203311399606

    authors： Bartoloni E,Ludovini V,Alunno A,Pistola L,Bistoni O,Crinò L,Gerli R

    更新日期：2011-08-01 00:00:00

  • From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link?

    abstract：:The heart lesions of rheumatic fever and the heart involvement in antiphospholipid syndrome (APS), have different clinical pictures. Yet, there are several common characteristics linking both diseases: 1) central nervous system (CNS) and heart involvement; 2) molecular mimicry between the a pathogen and the origin of ...

    journal_title：Lupus

    pub_type： 杂志文章,评审

    doi：10.1191/0961203305lu2203oa

    authors： Blank M,Aron-Maor A,Shoenfeld Y

    更新日期：2005-01-01 00:00:00

  • Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy.

    abstract：:We report a case of a patient with clinical features of progressive supranuclear palsy and raised titres of anticardiolipin antibodies in blood, thrombocytopenia and livedo reticularis on skin. Magnetic resonance imaging of brain and isotope scan of brain were distinctive of vascular disorder. ...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1191/0961203303lu242CR

    authors： Reitblat T,Polishchuk I,Dorodnikov E,Aladjem Z,Turiansky L,Zamir D,Kahana E

    更新日期：2003-01-01 00:00:00

  • Vulvar intraepithelial neoplasia in a young woman with systemic lupus erythematosus: a case report.

    abstract：:Diagnosing vulvar intraepithelial neoplasia in a young woman presenting mainly with skin manifestations of lupus and with no other risk factors is a major challenge. The case of a 27-year-old woman with systemic lupus erythematosus and vulvar intraepithelial neoplasia is described. Although progression of vulvar intra...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203309345742

    authors： Stepanić V,Corusić A,Matković V,Sentić M,Bosnić D,Mahovlić V

    更新日期：2010-01-01 00:00:00

  • Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.

    abstract：OBJECTIVE:Arthritis is frequently seen in human lupus, but rarely in lupus models. Pristane-induced lupus (PIL) can be induced in various mouse strains such as BALB/c and C57BL/6. We herein characterize clinical and histological features of arthritis in the context of systemic lupus and provide a prudent comparison wit...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203313492869

    authors： Leiss H,Niederreiter B,Bandur T,Schwarzecker B,Blüml S,Steiner G,Ulrich W,Smolen JS,Stummvoll GH

    更新日期：2013-07-01 00:00:00

  • Acquired C1q deficiency caused by monoclonal paraproteinaemia.

    abstract：:Acquired C1q deficiency secondary to anti C1q auto-antibodies may result in the hypocomplementaemic urticarial vasculitis syndrome and may also be seen in active systemic lupus erythematosus. Some patients with acquired C1 inhibitor deficiency are found to have an underlying malignancy, most commonly lymphoma. We repo...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/096120330000900113

    authors： Gordon MM,Lucie N,Porter D

    更新日期：2000-01-01 00:00:00

  • Sulpha allergy in lupus patients: a clinical perspective.

    abstract：:Systemic lupus erythematosus is a chronic, relapsing autoimmune disease that can affect multiple organ systems. An increased prevalence of drug allergy has been reported in lupus patients compared with the general population. Using a cohort of 417 lupus patients, we found a history of sulpha allergy in 27.3% of patien...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203307086640

    authors： Jeffries M,Bruner G,Glenn S,Sadanandan P,Carson CW,Harley JB,Sawalha AH

    更新日期：2008-03-01 00:00:00

  • Antiphospholipid antibodies in an in vivo thrombosis model in mice.

    abstract：:The mouse model described in this study offers a unique method of determining the characteristics and mechanism(s) of action of aCL antibodies in thrombosis in vivo. In addition, this animal model enables the study of the kinetics of formation and dissolution of thrombus, as well as clot area, to be studied in a dynam...

    journal_title：Lupus

    pub_type： 杂志文章,评审

    doi：10.1177/096120339400300408

    authors： Pierangeli SS,Harris EN

    更新日期：1994-08-01 00:00:00

  • Familial SLE: sustained drug-free remission in a mother successfully treated for anal cancer, but development of SLE in a 16-year old daughter.

    abstract：:The immunopathogenesis of systemic lupus erythematosus has been thoroughly investigated recently, and genome-wide association studies have identified genes statistically associated with lupus. However, the progression to overt disease is dependent on the activation of environmental factors ('triggers'), among which oe...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203311433138

    authors： Catania G,Rossi E,Marmont A

    更新日期：2012-05-01 00:00:00

  • Annexin A2: biology and relevance to the antiphospholipid syndrome.

    abstract：:Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....

    journal_title：Lupus

    pub_type： 杂志文章,评审

    doi：10.1177/0961203308095329

    authors： Cockrell E,Espinola RG,McCrae KR

    更新日期：2008-10-01 00:00:00

  • New immunosuppresor strategies in the treatment of murine lupus nephritis.

    abstract：:Renal involvement in systemic lupus erythematosus is a common complication that significantly worsens morbidity and mortality. Although treatment with corticosteroids and cytotoxic drugs may be useful in many cases, morbidity associated with these drugs and the relapsing nature of the disease make it necessary to deve...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203306073136

    authors： Alperovich G,Rama I,Lloberas N,Franquesa M,Poveda R,Gomà M,Herrero-Fresneda I,Cruzado JM,Bolaños N,Carrera M,Grinyó JM,Torras J

    更新日期：2007-01-01 00:00:00

  • The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.

    abstract：:Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on patients' daily lives. Herein, we describe the responsiveness of the LIT and LupusQoL to changes in disease activity, using the systemic lupus erythematosus resp...

    journal_title：Lupus

    pub_type： 杂志文章,多中心研究

    doi：10.1177/0961203316667494

    authors： Devilliers H,Bonithon-Kopp C,Jolly M

    更新日期：2017-04-01 00:00:00

  • High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage.

    abstract：:The main objective of this study is to describe the presence of infections in patients with pulmonary haemorrhage and systemic lupus erythematosus. Patients with systemic lupus erythematosus and pulmonary haemorrhage were thoroughly evaluated in the first 48 hours with imaging plus bronchoscopy and bronchoalveolar flu...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203307086930

    authors： Rojas-Serrano J,Pedroza J,Regalado J,Robledo J,Reyes E,Sifuentes-Osornio J,Flores-Suárez LF

    更新日期：2008-04-01 00:00:00

  • Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

    abstract：OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic, multisystemic, immune-mediated disorder associated with a substantial hospitalization risk. As a comparatively rare disease, there is a sparsity of research examining the burden of hospital admission in the contemporary era. We aim to describe national trends ...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203319853357

    authors： Hannah J,Galloway J,Kaul A

    更新日期：2019-06-01 00:00:00

  • Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies.

    abstract：:The presence of antibodies against the complex of prothrombin and phosphatidylserine (aPS/PT) more significantly correlates with manifestations of antiphospholipid syndrome (APS) and with the presence of lupus anticoagulants (LA) than antibodies against prothrombin bound to oxygenated polystyrene (aPT-A). To investiga...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203307078680

    authors： Horita T,Ichikawa K,Kataoka H,Yasuda S,Atsumi T,Koike T

    更新日期：2007-01-01 00:00:00

  • Infliximab-induced discoid lupus erythematosus.

    abstract：:Anti-tumor necrosis factor-alpha (TNF-α) immunotherapy is currently used in the treatment of various inflammatory diseases such as rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. Infliximab is a chimeric monoclonal antibody that binds to transmembrane-bound and soluble...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203313479423

    authors： Cemil BC,Atas H,Canpolat F,Akca Y,Sasmaz R

    更新日期：2013-04-01 00:00:00

  • GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

    abstract：BACKGROUND:There is no report about the association between GATA3 rs3824662 polymorphism and systemic lupus erythematosus (SLE). OBJECTIVE:To investigate the possible role of GATA3 rs3824662 polymorphism as a susceptibility risk factor for either adult SLE (aSLE) or pediatric SLE (pSLE) and to evaluate its role in the...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203318804894

    authors： Mosaad YM,Hammad A,Elghzaly AA,Tawhid ZME,Hammad EM,Showma A,Abdelsalam R,Elmoughy A,Fawzy IM,Anber N

    更新日期：2018-11-01 00:00:00

  • Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.

    abstract：:Patients with antiphospholipid syndrome (APS) produce antiphospholipid antibodies (aPL) and develop vascular thrombosis that may occur in large or small vessels in the arterial or venous beds. On the other hand, many individuals produce aPL and yet never develop thrombotic events. Toll-like receptor 4 (TLR4) appears t...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203315603146

    authors： Laplante P,Fuentes R,Salem D,Subang R,Gillis MA,Hachem A,Farhat N,Qureshi ST,Fletcher CA,Roubey RA,Merhi Y,Thorin É,Levine JS,Mackman N,Rauch J

    更新日期：2016-02-01 00:00:00

  • Vaccination, atherosclerosis and systemic lupus erythematosus.

    abstract：:Atherosclerosis is an inflammatory disease, leading to the formation of pro-inflammatory and pro-oxidative lipids that generate an immune response. Several antigens have been shown to activate the immune response and affect the development of atherogenesis. Systemic lupus erythematosus is an autoimmune and inflammator...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203309345725

    authors： Carvalho JF,Pereira RM,Shoenfeld Y

    更新日期：2009-11-01 00:00:00

  • Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.

    abstract：:Tubulointerstitial injury is found frequently in lupus nephritis. Immune complex deposits can occur in the tubular basement membranes (TBMs), although its significance in lupus nephritis patients remains unclear. This study assessed the clinical and prognostic features of lupus nephritis patients with TBM deposits in ...

    journal_title：Lupus

    pub_type： 杂志文章,多中心研究

    doi：10.1177/0961203317732407

    authors： Wang H,Xu J,Zhang X,Ren YL,Cheng M,Guo ZL,Zhang JC,Cheng H,Xing GL,Wang SX,Yu F,Zhao MH

    更新日期：2018-04-01 00:00:00

  • Ultrasonographic abnormalities and inter-reader reliability in Danish patients with systemic lupus erythematosus - a comparison with clinical examination of wrist and metacarpophalangeal joints.

    abstract：OBJECTIVES:We aimed to determine 1) ultrasound (US) abnormalities in patients with systemic lupus erythematosus (SLE) with and without hand arthralgia at the day of examination compared with clinical evaluation and healthy controls, and 2) inter-observer reliability of the US abnormalities. METHODS:Thirty-three female...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203314561666

    authors： Dreyer L,Jacobsen S,Juul L,Terslev L

    更新日期：2015-06-01 00:00:00

  • Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.

    abstract：INTRODUCTION:Creatine supplementation has emerged as a promising non-pharmacological therapeutic strategy to counteract muscle dysfunction and low lean mass in a variety of conditions, including in pediatric and rheumatic diseases. The objective of this study was to examine the efficacy and safety of creatine supplemen...

    journal_title：Lupus

    pub_type： 杂志文章,随机对照试验

    doi：10.1177/0961203314546017

    authors： Hayashi AP,Solis MY,Sapienza MT,Otaduy MC,de Sá Pinto AL,Silva CA,Sallum AM,Pereira RM,Gualano B

    更新日期：2014-12-01 00:00:00

  • Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.

    abstract：:Anti-phospholipid antibodies are common in patients in the Hopkins' Lupus Cohort: 47% have anti-cardiolipin, 32.5% anti-beta(2)-glycoprotein I and 26% lupus anticoagulant (by dRVVT confirmatory testing). Systemic lupus erythematosus patients with the lupus anticoagulant at baseline have a 50% chance of a deep venous t...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203309360541

    authors： Petri M

    更新日期：2010-04-01 00:00:00

  • A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab.

    abstract：:Belimumab is a monoclonal antibody against soluble B-lymphocyte stimulator, an essential growth factor for B-cell maturation and activation, which was approved by the US FDA in 2011 for patients with active autoantibody-positive systemic lupus erythematosus (SLE) who have failed standard treatment. Here we present the...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203314524292

    authors： Fredericks CA,Kvam KA,Bear J,Crabtree GS,Josephson SA

    更新日期：2014-06-01 00:00:00

  • Pathological manifestation of autoimmune myocarditis is detected prior to glomerulonephritis in a murine model of lupus nephritis.

    abstract：OBJECTIVE:Since enhanced cardiac magnetic resonance imaging (cMRI) signals have been associated with lupus disease activity in humans prior to renal failure and novel, cardiac-focused therapeutic strategies could be investigated with an associated animal model, autoimmune myocarditis was characterized in murine lupus n...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203320948959

    authors： Young NA,Jablonski K,Schwarz E,Okafor I,Hampton J,Valiente GR,Henry C,Harb P,Barger J,Bratasz A,Kalyanasundaram A,Ardoin SP,Jarjour WN

    更新日期：2020-11-01 00:00:00

  • Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.

    abstract：:The objective of this study was to assess the prevalence, clinical, histological and immunological characteristics, and the long-term outcome of polymyositis- (PM) and dermatomyositis- (DM) associated lung disease, and to define subgroups of lung-associated inflammatory myopathies. This retrospective study included 81...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1191/0961203305lu2158oa

    authors： Selva-O'Callaghan A,Labrador-Horrillo M,Muñoz-Gall X,Martínez-Gomez X,Majó-Masferrer J,Solans-Laque R,Simeon-Aznar CP,Morell-Brotard F,Vilardell-Tarrés M

    更新日期：2005-01-01 00:00:00

  • Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.

    abstract：OBJECTIVES:The aims of this study were to clarify the activation of complement pathways in patients with lupus nephritis (LN), and to elucidate the association between these complement activation types and clinical outcomes. METHODS:We enrolled 115 patients with biopsy-proven LN from 2003 to 2016 from the lupus cohort...

    journal_title：Lupus

    pub_type： 杂志文章

    doi：10.1177/0961203320925165

    authors： Kim H,Kim T,Kim M,Lee HY,Kim Y,Kang MS,Kim J

    更新日期：2020-07-01 00:00:00